HomeCorporateElanco Leadership to Outline Portfolio Transformation at Morgan Stanley Healthcare Conference
Corporate

Elanco Leadership to Outline Portfolio Transformation at Morgan Stanley Healthcare Conference

Animal Health India Editorial Team
By Animal Health India Editorial Team
0
4
elanco-portfolio-transformation-morgan-stanley-conference
elanco-portfolio-transformation-morgan-stanley-conference

GREENFIELD, IND. — Elanco Animal Health Incorporated has confirmed its executive participation at the 24th Annual Morgan Stanley Global Healthcare Conference. Chief Executive Officer Jeff Simmons will outline the company’s long-term commercial posture, pipeline execution, and debt-deleveraging strategy amid major structural shifts in companion animal and livestock markets.

elanco-portfolio-transformation-morgan-stanley-conference
elanco-portfolio-transformation-morgan-stanley-conference

Key Strategic Themes Expected

  • Navigating Loss of Exclusivity: As older parasiticide platforms hit patent cliffs, Elanco is highlighting its next-generation companion animal pipeline—specifically focusing on recently launched dermatological and antiparasitic formulations.

  • Monoclonal Antibody Expansion: Updates on commercial adoption pathways for novel biological therapies targeting chronic pain and canine dermatological conditions.

  • Livestock Innovation & Sustainability: Details on expanding adoption of enteric methane-reducing feed additives and farm-animal health interventions aimed at reducing antimicrobial dependency in food production chains.

Previous article
Boehringer Ingelheim Rolls Out SCOVELLA®: First SGLT-2 Inhibitor for Equine Hyperinsulinemia
Next article
Scotland’s Rural College Launches $10M Centre for Animal Welfare Science
Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES